Our product development team (PDT) serve as the liaison between industry collaborators, machine learning scientists, and clinical experts working together to improve patient care. Our interdisciplinary teams develop software products (e.g., SaMD) through industry sponsored co-development partnerships.
Service offerings range from product ideation to SaMD development.
Our mission is to develop innovative products and provide clinical research support, using effective and compliant solutions to optimize data quality and meet our customers’ needs.
We provide our customers with a service in accordance with a pre-defined scope of tasks, agreed costing structure, and proposed timeline.
We are committed to complying with the regulatory needs of customers and achieving customer satisfaction through the use and continual improvement of quality procedures as part of an ISO 9001:2015 Quality Management System.
Clinical apps make up 80 percent of our project portfolio, followed by smart devices (15 percent) and operations (5 percent).
Most of our project portfolio consists of MRI-related modalities, making up 30 percent of our portfolio. CT makes up 25 percent, while another 25 percent consists of other imaging (i.e., PET, X-ray, mammography, digital breast tomosynthesis, EKG, echo, EHR). Ultrasound makes up 20 percent of our project portfolio.
Our projects include cardiology (20 percent), brain (20 percent), breast (10 percent), and spine (10 percent). Forty percent is various organs (i.e., abdomen, adrenal, kidney, liver, prostrate, uterine).